A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

NCT00206284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD Without Erosive Esophagitis

Interventions

DRUG: AZD0865

Sponsor

AstraZeneca